07:00 , May 27, 1997 |  BC Week In Review  |  Company News

Bio-Fluorescent, Immune Network Research Ltd. deal

The companies terminated their second attempt to merge (see BioCentury March 3). BFTK said it would pursue licensing or otherwise acquiring IMM's rights to an immune system disease treatment under development. Bio-Fluorescent Technologies Inc. (BFTK),...
08:00 , Mar 3, 1997 |  BC Week In Review  |  Company News

Bio-Fluorescent, Immune Network Research Ltd. deal

The companies signed a definitive agreement to merge (see BioCentury Feb. 18). BFTK will issue 9 million common shares and stock options for up to 717,000 shares of common stock Bio-Fluorescent Technologies Inc. (BFTK), Scottsdale,...
08:00 , Feb 18, 1997 |  BC Week In Review  |  Company News

Bio-Fluorescent, Immune Network Research Ltd. deal

BFTI reached an agreement in principal to acquire IMM for 9 million shares. BFTI has about 15 million shares outstanding prior to the merger. IMM develops monoclonal antibody-based products and vaccines to treat AIDS and...
08:00 , Nov 4, 1996 |  BC Week In Review  |  Company News

Bio-Fluorescent, Immune Network Research Ltd. deal

BFTI ceased negotiations to merge with IMM (see BioCentury Oct. 28). BFTI said that a VSE-listed company cannot enter a merger for a period of one year following its creation, which IMM completed less than...
08:00 , Oct 28, 1996 |  BC Week In Review  |  Company News

Bio Fluorescent Technologies Inc., Immune Network Research Ltd. deal

BFTI said it intends to merge with IMM, a developer of monoclonal antibody-based products and vaccines to treat AIDS and other immune system disorders. BFTI, a developer of diagnostics for viral diseases, would issue an...
08:00 , Jan 2, 1996 |  BC Week In Review  |  Clinical News

Bio Fluorescent Technologies Inc. regulatory update

BFTI's rapid assay tests for HIV 1/2 and hepatitis B were approved for sale in Argentina. The tests provide results in 7 to 10 minutes without requiring laboratory equipment or technicians, BFTI said. Bio Fluorescent...